Drug Shortage Report for TARO-DOCUSATE

Last updated on 2022-01-06 History
Report ID 143611
Drug Identification Number 00716731
Brand name TARO-DOCUSATE
Common or Proper name DOCUSATE SODIUM
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) DOCUSATE SODIUM
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code A06AA
ATC description DRUGS FOR CONSTIPATION
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2021-07-29
Estimated end date 2021-12-23
Actual end date 2022-01-04
Shortage status Resolved
Updated date 2022-01-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-08-04 English Compare
v2 2021-08-04 French Compare
v3 2021-08-04 English Compare
v4 2021-08-04 French Compare
v5 2021-08-20 English Compare
v6 2021-08-20 French Compare
v7 2021-08-24 English Compare
v8 2021-08-24 French Compare
v9 2021-09-15 English Compare
v10 2021-09-15 French Compare
v11 2021-10-13 English Compare
v12 2021-10-13 French Compare
v13 2021-10-21 English Compare
v14 2021-10-21 French Compare
v15 2021-11-26 English Compare
v16 2021-11-26 French Compare
v17 2021-12-07 English Compare
v18 2021-12-07 French Compare
v19 2022-01-06 English Compare
v20 2022-01-06 French Compare

Showing 1 to 20 of 20